Docking and molecular dynamics simulation study of EGFR1 with EGF-like peptides to understand molecular interactions

D Raja Sudhakar1, Kalaiarasan P2, Naidu Subbarao1

  • 1School of Computational and Integrative Sciences, Jawaharlal Nehru University, New Delhi-110067, India. nsrao.jnu@gmail.com.

Molecular Biosystems
|April 14, 2016
PubMed

Insights

This study identifies key amino acid residues in epidermal growth factor receptors (EGFRs) crucial for receptor activation and dimerization. Understanding these residues could lead to new cancer therapies targeting EGFR signaling pathways.

Area of Science:

  • Molecular biology
  • Biochemistry
  • Cancer research

Background:

  • Epidermal growth factor receptors (EGFRs) are key regulators of cell growth and division, often implicated as oncogenes.
  • EGFR activation involves ligand binding, dimerization, and subsequent kinase activity, critical processes in cancer development.
  • The varying binding affinities of EGF-like growth factors suggest complex conformational changes in EGFR.

Purpose of the Study:

  • To predict critical amino acid residues involved in EGFR activation and dimerization.
  • To understand the conformational changes in the extracellular region of EGFR1 upon growth factor binding.
  • To identify residues essential for initiating downstream signaling pathways linked to cancer.

Main Methods:

  • Protein-peptide docking using HADDOCK.
  • Molecular dynamics simulations of EGFR1-ligand complexes using Gromacs.
  • Analysis of dynamic domain movements to study conformational changes.

Main Results:

  • Predicted differential binding affinities of various growth factors (EGF, TGF-α, HB-EGF, Betacellulin) to EGFR1.
  • Identified specific amino acid residues (Cys305, Gly307, Arg310, Val312) exhibiting altered behavior.
  • These residues are implicated in EGFR dimerization and tyrosine kinase domain activation.

Conclusions:

  • Specific amino acid residues play a vital role in EGFR activation and dimerization.
  • The identified residues are potential targets for modulating EGFR signaling in cancer.
  • Further research into these residues could inform the development of targeted cancer therapies.